What You Should Know:
- PatchMD, a pioneer in transdermal nutrient delivery, has unveiled its new GLP-1 Support Patch Collection, designed to provide essential support for individuals using GLP-1 receptor agonist medications such as Ozempic, Wegovy, and Mounjaro for weight management.
- GLP-1 receptor agonists have revolutionized medical weight loss, but they often come with side effects like nausea and appetite suppression, and can lead to nutrient deficiencies.
Why
Read More
GLP-1
Teladoc Health, Eli Lilly Partner to Add GLP-1 Self-Pay Option to Comprehensive Weight Care
What You Should Know:
- Teladoc Health, the global leader in virtual care announced a partnership with Gifthealth, a digital pharmacy platform and partner of Eli Lilly's LillyDirect program, to improve access to Zepbound® (tirzepatide) for weight management.
- The collaboration will enable eligible Teladoc Health members enrolled in the Comprehensive Weight Care Program to receive convenient and affordable access to this FDA-approved medication.
Streamline Access to Tirzepatide
Read More
Wondr Health Expands Weight Loss Program with Support for GLP-1 Users
What You Should Know:
- Wondr Health, a leader in virtual metabolic health programs, has announced the expansion of its weight and obesity care solution, Wondr Plus.
- The enhancement provides comprehensive lifestyle support and nutrition counseling for employees using GLP-1 weight-loss medications, addressing the challenges of medication adherence and side effects.
Addressing the Need for GLP-1 Support
While GLP-1 medications have shown promising results for weight loss,
Read More
Bariatric Surgeries Decline as GLP-1s Use Rises, Impacting Hospital Margins
What You Should Know:
- A new report from Strata Decision Technology reveals a significant decline in the number of bariatric surgeries performed in U.S. hospitals in recent years.
- The trend coincides with the rising popularity of weight-loss medications like semaglutide (GLP-1s), which have gained widespread adoption since their approval for chronic weight management.
Declining Surgical Volumes
Strata's analysis of data from 809 hospitals nationwide shows a clear
Read More
HLTH: Waltz Health and Noom Partner to Offer Affordable GLP-1 Weight Loss Program
What You Should Know:
- Waltz Health, a digital health company specializing in medication pricing and distribution, and Noom, a leader in digital health and chronic disease prevention, have announced a unique partnership to provide employers and health plans with a comprehensive and affordable weight loss program.
- The collaboration will leverage Waltz Connect, Waltz Health's innovative platform, to streamline access to GLP-1 medications, making them more accessible and
Read More
Dandelion Health Launches Clinical AI Marketplace + GLP-1 Study
What You Should Know:
- Dandelion Health, a real-world data (RWD) and clinical AI platform, today announced findings from a study that suggests GLP-1 medications may be effective in preventing cardiovascular disease (CVD) in a significantly larger population than previously thought.
- This research, conducted using validated AI on Dandelion's newly launched Clinical AI Marketplace, opens the door for a new era of precision medicine and personalized care in cardiometabolic
Read More
Noom Launches $149 GLP-1 Weight Loss Program with Sustainable Approach
What You Should Know:
- Noom, a digital healthcare company, is shaking up the weight loss industry with the launch of Noom GLP-1Rx, an innovative program offers affordable, accessible, and sustainable weight loss by combining compounded GLP-1 injections with Noom's proven behavioral change program.
- Noom GLP-1Rx delivers highly efficacious medications to the door within seven days starting at $149 and pairs those powerful medications with Noom GLP-1 Companion with Muscle
Read More
OMNY Health Launches GLP-1 Data Network to Advance Research
What You Should Know:
- OMNY Health, a healthcare ecosystem specializing in data partnerships, today announced the launch of its GLP-1 data network.
- The GLP-1 data network aims to democratize access to healthcare data and empower researchers, clinicians, and life sciences companies to gain valuable insights into GLP-1 therapies.
Addressing Data Gaps in GLP-1 Research
Despite the growing use of GLP-1 agonists, there remains a significant lack of comprehensive data on
Read More
Heart Health in the GLP-1 Era: The Role of Remote Patient Monitoring
According to the American Heart Association, nearly half of all adults in the U.S. have high blood pressure. Recent studies have suggested that effectively treating obesity with GLP-1 agonists may be key to improving overall heart health. These findings are promising — but additional study is necessary, further highlighting the need for accurate GLP-1 patient data and consistent at-home health monitoring.
Healthcare providers can benefit from high-precision remote monitoring tools like
Read More
FuturHealth Combines GLP-1 Medications with Personalized Nutrition
What You Should Know:
- FuturHealth, a leader in personalized weight-loss solutions launches its Custom Meal Plans. Designed to complement the growing popularity of GLP-1 medications, the new offering provides a comprehensive approach to weight management and long-term health.
- As the use of GLP-1 medications surges, FuturHealth recognizes the need for a holistic approach to weight loss. By combining personalized meal plans with medication, FuturHealth aims to help individuals
Read More
